Neuromedex

What Neuromedex does

Neuromedex GmbH is a privately held German medical technology company headquartered in Hamburg-Niendorf, founded in 1976 and operating from a combined office and in-house cleanroom production facility. The company is narrowly specialized in single-use neurosurgical products, with the VentrEX® external ventricular drainage (EVD) system as its platform anchor and a portfolio that spans EVD systems and mounts, antimicrobial (VentriGuard®) and transparent (VentriClear®) ventricular and lumbar catheters, the VentriFix® catheter fixation device, Brainlab- and Medtronic-compatible brain biopsy cannulas, low-vacuum drainage products (NeuroVac and NeuroVac PRO), and small surgical disposables. Its core proprietary technology is the patented VentriGuard® silver-ion antimicrobial matrix — a zeolite-based reservoir embedded in catheter material that delivers continuous antimicrobial protection for up to 28 days, including against antibiotic-resistant strains and biofilm formation. Products are designed and manufactured in Germany and certified to ISO 13485:2016, with the portfolio submitted for EU MDR approval (transitional coverage extending at least through 2027).

The company sells primarily to acute-care hospitals with neurosurgery departments and neuro-intensive care units, addressing pain points around catheter-associated infection, catheter migration, and workflow complexity during prolonged EVD use. Documented clinical outcomes include CSF leak-rate reduction from 26.2% to 8.8% and catheter migration reduction of more than 50% with VentriFix versus standard sutures (Queen's Medical Centre study), as well as NeuroVac PRO retaining 87.5% drainage performance versus 50% for conventional drains. The go-to-market is direct enterprise field sales — Head of Marketing & Sales Alexander Schultze, Regional Sales Manager Sascha Betz, Sales Manager Sven Wokel, and International Sales Manager Ursula Junge cover more than 30 countries, supplemented by conferences (ANIM, WHX Dubai) and the EVD Academy digital training platform. Pricing is not publicly disclosed and is determined through direct sales consultation typical of B2B specialty medical devices.

In October 2025, Giuseppe Usai joined as a second Managing Director to drive commercial direction and growth in existing and new markets, while Markus Drewes continues to lead operational and administrative functions. The business model is single-stream B2B hardware sales of disposable neurosurgical devices; revenue figures are not publicly disclosed, but headcount of approximately 80 employees and cumulative production of more than 700,000 EVD units since 1976 are consistent with a focused, mid-sized specialty OEM rather than a high-volume commodity manufacturer.

Name

Neuromedex

Legal name

Neuromedex GmbH

Website

https://neuromedex.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

51–100 employees

Short description

Neuromedex GmbH is a privately held German medical technology company in Hamburg that designs and manufactures single-use neurosurgical products, principally the VentrEX® external ventricular drainage system and VentriGuard® antimicrobial catheters, sold directly to hospitals in 30+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Neuromedex generates revenue through direct B2B sales of single-use neurosurgical medical devices to hospitals, healthcare facilities, and surgical centers. The company sells its complete product portfolio including EVD systems, catheters, and surgical disposables through direct sales channels to healthcare providers worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Neuromedex designs, manufactures and sells precision-engineered single-use neurosurgical medical devices, with its core offering being the VentrEX modular external ventricular drainage (EVD) system and a complementary portfolio of antimicrobial ventricular and lumbar catheters (VentriGuard with silver-ion technology), transparent catheters (VentriClear), catheter fixation systems (VentriFix), brain biopsy cannulas, low-vacuum drainage solutions, and surgical disposables. All products are manufactured in-house in Hamburg, Germany, and sold directly to hospitals, neurosurgery departments, and neurointensive care units worldwide.

Product overview

Neuromedex is a German medical technology company specializing in neurosurgical products, organized as a platform-based portfolio centered on the VentrEX® EVD System family. The core offering consists of modular external ventricular drainage systems (VentrEX® EVD and VentrEX® Complete) supported by the VentrEX® EVD Mount, complemented by specialized catheters including antimicrobial options (VentriGuard® with silver-ion technology and VentriClear® transparent catheters) and lumbar catheters (standard and PRO variants). Additional products include VentriFix® catheter fixation, Brain Biopsy Solutions (BBC Cannulas and Navigation Markers), Low Vacuum Drainage Solutions (NeuroVac and NeuroVac PRO), and Surgical Disposables. The company also provides the EVD Academy for training and product tutorials. All products are designed, manufactured, and precision-engineered in Hamburg, Germany, with a focus on patient safety and infection prevention.

Differentiator

Problem solved

Functional benefit

Brands

• VentrEX®: Modular external ventricular drainage (EVD) system designed for seamless integration into clinical infrastructure, focused on patient safety and workflow optimization.
• VentriGuard®
• VentriClear®
• VentriFix®
• NeuroVac
• NeuroVac PRO
• BBC Brain Biopsy Cannula
• EVD Academy

Products and services

• VentrEX EVD System

Quantifiable outcome

• CSF leak rates reduced from 26.2% to 8.8% with VentriFix catheter fixation
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Integra LifeSciences: Integra LifeSciences is a large US-headquartered neurosurgery and neuro critical care device company with a direct EVD, ICP monitoring, and neurosurgical catheter portfolio, making it the closest like-for-like competitor in the same niche as Neuromedex.
• Spiegelberg GmbH: Spiegelberg is a Hamburg-based neurosurgery device specialist focused on ICP monitoring and EVD systems. It directly competes with Neuromedex in the same German and European neurosurgery market with overlapping product categories.
• Natus Medical: Natus Medical is a neuro-focused device company offering neurodiagnostic, neuro critical care, and neurosurgery products including EVD-related offerings, making it a focused peer in the same clinical workflow.

Broad incumbents

• Medtronic: Medtronic operates a large neurosurgery division with EVD catheters, navigation systems (StealthStation), and biopsy instruments. As a diversified incumbent with far greater scale, it overlaps with Neuromedex's catheter and biopsy cannula offerings but competes from a much broader portfolio.
• B. Braun: B. Braun is a major German medical device and pharmaceutical company with a neurosurgery catheter and drainage portfolio. Its Aesculap division overlaps with Neuromedex's EVD and surgical disposable offerings, making it a relevant broad incumbent competitor.
• Stryker: Stryker's neurosurgery business spans neuro instruments, drainage, and image-guided surgery tools. While broader than Neuromedex's portfolio, Stryker is a relevant incumbent competing for neurosurgery hospital contracts.
• Penumbra Inc: Penumbra is a neurovascular-focused device company offering catheters and aspiration systems for stroke and neurosurgery. While oriented toward neurovascular intervention rather than EVD, it competes for neurosurgery hospital budgets and catheter spend.
• Elekta: Elekta is a Sweden-based leader in radiation therapy and radiosurgery with neurosurgery applications. Its Leksell product family sits adjacent to Neuromedex's neurosurgery focus and competes for neurosurgery capital equipment budgets.
• Smith & Nephew: Smith & Nephew is a diversified global MedTech company with a sports medicine and surgical devices portfolio. While not focused on neurosurgery specifically, its single-use surgical disposables and advanced wound management compete in adjacent hospital categories relevant to Neuromedex's broader portfolio.

Regional players

• Mölnlycke Health Care: Mölnlycke is a Swedish-headquartered MedTech company specializing in single-use surgical products and wound care. It overlaps with Neuromedex's surgical disposables category from a European/regional angle but does not directly compete in EVD catheters.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/neuromedex

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuromedex